Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Skin Irritation Study of BAY H006689 (Naproxen Gel) in Healthy Volunteers
NCT06511973Phase 1Completed
- Sponsor
- Bayer
- Start
- Jul 2024
- Primary completion
- Aug 2024
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 1, randomised, double-blind trial of naproxen in myalgia and arthralgia (4 arms), sponsored by Bayer. Primary endpoint: Skin sensitization potential measured by the mean and total cumulative irritancy score at 22 days. Started Jul 2024; status: completed.
02
Drugs
naproxen
03
Conditions
myalgiaarthralgia
Beyond the preview
Go deeper on NCT06511973.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT06511973.